Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
BMC Musculoskelet Disord ; 24(1): 624, 2023 Aug 01.
Article in English | MEDLINE | ID: mdl-37528404

ABSTRACT

BACKGROUND: Myofascial Pain Syndrome (MPS) is a common pain disorder. Diagnostic criteria include physical findings which are often unreliable or not universally accepted. A precise biosignature may improve diagnosis and treatment effectiveness. The purpose of this study was to assess whether microanalytic assays significantly correlate with characteristic clinical findings in people with MPS. METHODS: This descriptive, prospective study included 38 participants (25 women) with greater than 3 months of myofascial pain in the upper trapezius. Assessments were performed at a university laboratory. The main outcome measures were the Beighton Index, shoulder range of motion, strength asymmetries and microanalytes: DHEA, Kynurenine, VEGF, interleukins (IL-1b, IL-2, IL-4, IL-5, IL-7, IL-8, IL-13), growth factors (IGF-1, IGF2, G-CSF, GM-CSF), MCP-1, MIP-1b, BDNF, Dopamine, Noradrenaline, NPY, and Acetylcholine. Mann-Whitney test and Spearman's multivariate correlation were applied for all variables. The Spearman's analysis results were used to generate a standard correlation matrix and heat map matrix. RESULTS: Mean age of participants was 32 years (20-61). Eight (21%) had widespread pain (Widespread Pain Index ≥ 7). Thirteen (34%) had MPS for 1-3 years, 14 (37%) 3-10 years, and 11 (29%) for > 10 years. The following showed strong correlations: IL1b,2,4,5,7,8; GM-CSF and IL 2,4,5,7; between DHEA and BDNF and between BDNF and Kynurenine, NPY and acetylcholine. The heat map analysis demonstrated strong correlations between the Beighton Index and IL 5,7, GM-CSF, DHEA. Asymmetries of shoulder and cervical spine motion and strength associated with select microanalytes. CONCLUSION: Cytokine levels significantly correlate with selected clinical assessments. This indirectly suggests possible biological relevance for understanding MPS. Correlations among some cytokine clusters; and DHEA, BDNF kynurenine, NPY, and acetylcholine may act together in MPS. These findings should be further investigated for confirmation that link these microanalytes with select clinical findings in people with MPS.


Subject(s)
Fibromyalgia , Myofascial Pain Syndromes , Humans , Female , Young Adult , Adult , Middle Aged , Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use , Prospective Studies , Acetylcholine/therapeutic use , Brain-Derived Neurotrophic Factor , Kynurenine/therapeutic use , Myofascial Pain Syndromes/diagnosis , Myofascial Pain Syndromes/therapy , Cytokines , Pain , Dehydroepiandrosterone
2.
J Neuroimmunol ; 335: 577022, 2019 10 15.
Article in English | MEDLINE | ID: mdl-31445380

ABSTRACT

An important extrahepatic consequence of Hepatitis C is its adverse impact on the central nervous system and cognitive performance. We aimed to determine whether there is a significant relationship between selected neurotransmitters and cytokines and cognitive performance in patients with Chronic Hepatitis C before and after achieving sustained virologic response (SVR). Pre-SVR, elevated kynurenine was associated with increased immediate and delayed visual memory, whereas post-SVR the positive associations are between kynurenine and immediate and delayed verbal memory. TGF-B was consistently negatively associated with both immediate and delayed visual memory pre- and post-SVR. These concomitant changes may have important clinical relevance.


Subject(s)
Cognition , Cytokines/blood , Hepatitis C, Chronic , Neurotransmitter Agents/blood , Adult , Antiviral Agents/therapeutic use , Benzimidazoles/therapeutic use , Female , Fluorenes/therapeutic use , Hepatitis C, Chronic/blood , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/drug therapy , Humans , Male , Middle Aged , Pilot Projects , Sofosbuvir , Sustained Virologic Response , Uridine Monophosphate/analogs & derivatives , Uridine Monophosphate/therapeutic use
3.
Liver Int ; 39(9): 1631-1640, 2019 09.
Article in English | MEDLINE | ID: mdl-30959554

ABSTRACT

BACKGROUND & AIMS: Chronic hepatitis C (CHC) has a negative impact on patient-reported outcomes (PROs). Although most CHC patients who achieve sustained virologic response (SVR) show an improvement in PRO scores, some continue to experience impairment in PROs. The aim was to investigate if serum biomarkers (selected neurotransmitters and cytokines) are associated with changes in PROs in CHC patients who achieve SVR. METHODS: Data were utilized from a prospective clinical trial of ledipasvir/sofosbuvir fixed-dose combination. Chronic genotype 1 HCV subjects without cirrhosis (N = 40, age: 45.3 ± 11.5, 48% male, 90% white) were treated for 12 weeks open label with 97% achieving SVR24. PRO questionnaires included Short Form-36 (SF-36), Fatigue Severity Scale (FSS), Beck Depression Inventory-II (BDI-II), Chronic Liver Disease Questionnaire-HCV (CLDQ-HCV) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F). Sera were used for measurement of selected neurotransmitters and cytokines. Data were collected at baseline and follow-up week 24. RESULTS: Changes in physical health correlated with changes in several biomarkers. BDNF negatively correlated with SF-36 physical health summary score (rho = -0.34, P < 0.05), SF-36 physical functioning (rho = -0.34, P < 0.05), SF-36 bodily pain (rho = -0.39, P < 0.05) and FACIT-F physical well-being (rho = -0.54, P < 0.001). Changes in emotional well-being (FACIT-F) were positively associated with changes in serotonin (rho = 0.34, P < 0.05), but negatively associated with changes in GABA and BDNF (rho = -0.4, P = 0.01, and rho = -0.35, P < 0.05 respectively). CONCLUSIONS: These data indicate relationships between PROs and serum biomarkers pre- and post-SVR in CHC. These concomitant changes may have important clinical relevance.


Subject(s)
Antiviral Agents/therapeutic use , Cytokines/metabolism , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/metabolism , Patient Reported Outcome Measures , Adult , Benzimidazoles/therapeutic use , Biomarkers , Drug Therapy, Combination , Female , Fluorenes/therapeutic use , Humans , Male , Middle Aged , Prospective Studies , Ribavirin/therapeutic use , Severity of Illness Index , Sofosbuvir/therapeutic use , Surveys and Questionnaires , Sustained Virologic Response , Uridine Monophosphate/analogs & derivatives , Uridine Monophosphate/therapeutic use
4.
BMC Med ; 16(1): 170, 2018 09 12.
Article in English | MEDLINE | ID: mdl-30205811

ABSTRACT

BACKGROUND: Non-alcoholic steatohepatitis (NASH) is among the leading causes of liver disease worldwide. It is increasingly recognized that the phenotype of NASH may involve a number of different pathways, of which each could become important therapeutic targets. The aim of this study is to use high resolution mass spectrometry (MS) and phosphoproteomics techniques to assess the serum proteome and hepatic phosphoproteome in subjects with NASH-related fibrosis. METHODS: Sixty-seven biopsy-proven NAFLD subjects with frozen sera and liver tissue were included. Reverse phase protein microarray was used to quantify the phosphorylation of key signaling proteins in liver and nano-liquid chromatography (LC)-MS was used to sequence target biomarkers in the serum. An image analysis algorithm was used to quantify the percentage of collagen (% collagen) using computer-assisted morphometry. Using multiple regression models, serum proteomes and phosphorylated hepatic proteins that were independently (p ≤ 0.05) associated with advanced fibrosis (stage ≥ 2) and higher % collagen were assessed. RESULTS: Phosphorylated signaling pathways in the liver revealed that apoptosis signal-regulating kinase 1, mitogen-activated protein kinase (ASK1-MAPK pathway involving ASK1 S38 (p < 0.02) and p38 MAPK (p = 0.0002)) activated by the inflammatory cytokine interleukin (IL-10) (p < 0.001), were independently associated with higher % collagen. LC-MS data revealed that serum alpha-2 macroglobulin (α2M) (p = 0.0004) and coagulation factor V (p = 0.0127) were independently associated with higher % hepatic collagen. CONCLUSIONS: Simultaneous profiling of serum proteome and hepatic phosphoproteome reveals that the activation of ASK1 S38, p38 MAPK in the liver, and serum α2M and coagulation factor V are independently associated with hepatic collagen deposition in patients with NASH. These data suggest the role of these pathways in the pathogenesis of NASH-related fibrosis as a potential therapeutic target.


Subject(s)
Chromatography, Liquid/methods , Collagen/metabolism , Liver Cirrhosis/pathology , Mass Spectrometry/methods , Non-alcoholic Fatty Liver Disease/metabolism , Non-alcoholic Fatty Liver Disease/pathology , Adult , Biomarkers/analysis , Biomarkers/metabolism , Collagen/analysis , Female , Humans , Liver Cirrhosis/metabolism , Male , Middle Aged , Nanotechnology/methods , Proteomics/methods
5.
Curr Gastroenterol Rep ; 20(6): 24, 2018 Apr 19.
Article in English | MEDLINE | ID: mdl-29675753

ABSTRACT

PURPOSE OF REVIEW: Obesity is currently seen in epidemic proportions globally and is one of the largest contributors to the development of NAFLD. The spectrum of NAFLD, particularly the progressive forms of NASH, is likely to become the leading cause of liver disease in the next decade. RECENT FINDINGS: Soluble molecules, encoded by the stomach tissue, have been shown to have pleiotropic effects in both central and peripheral systems involved in energy homeostasis and obesity regulation. As such, the stomach is one of the important players in the complex, multi-system deregulation leading to obesity and NAFLD. The understanding of the stomach tissue as an active endocrine organ that contributes to the signaling milieu leading to the development of obesity and NAFLD is crucial.


Subject(s)
Gastric Mucosa/metabolism , Gastrointestinal Hormones/physiology , Non-alcoholic Fatty Liver Disease/genetics , Obesity/genetics , Brain/physiology , Endocrine Glands/metabolism , Endocrine Glands/physiopathology , Enteroendocrine Cells/metabolism , Gastrointestinal Hormones/genetics , Gene Expression , Humans , Non-alcoholic Fatty Liver Disease/physiopathology , Obesity/physiopathology , Stomach/physiopathology
8.
J Hepatol ; 65(1 Suppl): S109-S119, 2016 10.
Article in English | MEDLINE | ID: mdl-27641981

ABSTRACT

Hepatitis C virus infection (HCV) affects approximately 170-200 million individuals globally. HCV is one of the primary causes of hepatocellular carcinoma (HCC) and cirrhosis and has been identified as the leading indication for liver transplantation in most Western countries. Because HCV is a systemic disease with hepatic, extrahepatic, economic and patient reported consequences, it is important for healthcare practitioners to understand the comprehensive and multi-faceted picture of this disease. In this context, it is important to fully appreciate the impact of HCV on the individual patient and the society. With the recent advent of the new generation of direct antiviral agents, the long standing goal of eradicating HCV in most infected patients has been accomplished. Therefore, now more than ever, it is critical to assess the total benefits of sustained virological response in a comprehensive manner. This should not be limited to the clinical benefits of HCV cure, but also to account for the improvement of patient reported health and economic outcomes of HCV cure. It is only through this comprehensive approach to HCV and its treatment that we will understand the full impact of this disease and the tremendous gains that have been achieved with the new antiviral regimens.


Subject(s)
Hepatitis C, Chronic , Antiviral Agents/economics , Antiviral Agents/therapeutic use , Bioethical Issues , Carcinoma, Hepatocellular/prevention & control , Cost of Illness , Disease Progression , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/economics , Hepatitis C, Chronic/virology , Humans , Liver Cirrhosis/prevention & control , Liver Neoplasms/prevention & control , Quality of Life , Sustained Virologic Response
9.
BMC Syst Biol ; 9 Suppl 2: S3, 2015.
Article in English | MEDLINE | ID: mdl-25879163

ABSTRACT

BACKGROUND: High-throughput technologies became common tools to decipher genome-wide changes of gene expression (GE) patterns. Functional analysis of GE patterns is a daunting task as it requires often recourse to the public repositories of biological knowledge. On the other hand, in many cases researcher's inquiry can be served by a comprehensive glimpse. The KEGG PATHWAY database is a compilation of manually verified maps of biological interactions represented by the complete set of pathways related to signal transduction and other cellular processes. Rapid mapping of the differentially expressed genes to the KEGG pathways may provide an idea about the functional relevance of the gene lists corresponding to the high-throughput expression data. RESULTS: Here we present a web based graphic tool KEGG Pathway Painter (KPP). KPP paints pathways from the KEGG database using large sets of the candidate genes accompanied by "overexpressed" or "underexpressed" marks, for example, those generated by microarrays or miRNA profilings. CONCLUSION: KPP provides fast and comprehensive visualization of the global GE changes by consolidating a list of the color-coded candidate genes into the KEGG pathways. KPP is freely available and can be accessed at http://web.cos.gmu.edu/~gmanyam/kegg/.


Subject(s)
Databases, Genetic , Gene Expression Profiling/methods , Signal Transduction , Software , Gene Expression Regulation , Internet
10.
Oncotarget ; 6(3): 1414-21, 2015 Jan 30.
Article in English | MEDLINE | ID: mdl-25638154

ABSTRACT

Aging is associated with an increase in a chronic, low-grade inflammation. This phenomenon, termed "inflammaging" is also a risk factor for both morbidity and mortality in the elderly. Frequent co-occurrence of chronic diseases, known as multi-morbidity, may be explained by interconnected pathophysiology of these conditions, most of which depend on its inflammatory component. Here we present an analysis of the U.S. National Health and Nutrition Examination Survey data collected between 1999 and 2008, for the presence, and the number, of chronic diseases along with HDL-cholesterol, C-reactive protein, white blood cell count, lymphocyte percent, monocyte percent, segmented neutrophils percent, eosinophils percent, basophils percent, and glycohemoglobin levels. Importantly, even after adjustment for age and BMI, many inflammatory markers continued to be associated to multi-morbidity. C-reactive protein (CRP) levels and Glasgow Prognostic Score (GPS) were most dramatically increased in parallel with an accumulation of chronic diseases, and may be utilized as multi-morbidity predictors. These observations point at background inflammation as direct, age-independent contributor to an accumulation of the disease burden. Our findings also suggest a possibility that systemic inflammation associated with chronic diseases may explain accelerated aging phenomenon previously observed among the patients with heavy disease burden.


Subject(s)
Aging/pathology , Inflammation/pathology , Adult , Age Factors , C-Reactive Protein/metabolism , Chronic Disease/epidemiology , Female , Glasgow Outcome Scale , Humans , Inflammation/epidemiology , Inflammation/metabolism , Male , Middle Aged , Morbidity , Risk Factors , United States/epidemiology
12.
BMC Gastroenterol ; 14: 72, 2014 Apr 09.
Article in English | MEDLINE | ID: mdl-24716593

ABSTRACT

BACKGROUND: Stomach is an integral part of the energy balance regulating circuit. Studies exploring the effects of cross-system changes in the energy homeostasis in stomach tissue are scarce. The proximity of the stomach to liver--the most common secondary target affected by obesity--suggests that these two organs are exposed to each other's local secretion. Therefore, we aimed at expression profiling of energy metabolism associated genes in the gastric tissue of obese non-alcoholic fatty liver disease (NAFLD) patients. METHODS: A total of 24 patients with histologically-proven NAFLD were included. In the gastric tissue, gene expression profiling of 84 energy metabolism associated genes was carried out. RESULTS: The accumulation of the fat in the liver parenchyma is accompanied by downregulation of genes encoding for carboxypeptidase E (CPE) and Interleukin 1B (IL1B) in the gastric mucosa of same patient. In patients with high grade hepatic steatosis, Interleukin 1 beta encoding gene with anorexigenic function, IL1B was downregulated. The levels expression of 21 genes, including ADRA2B, CNR1 and LEP were significantly altered in the gastric tissue of NAFLD patients with hepatic inflammation. There were also indications of an increase in the opioid signaling within gastric mucosa that may results in a shift to proinflammatory environment within this organ and contribute to systemic inflammation and the pathogenic processes in hepatic parenchyma. CONCLUSIONS: We have shown differential expression of energy metabolism associated genes in the gastric tissue of obese NAFLD patients. Importantly, these gene expression profiles are associated with changes in the hepatic parenchyma as reflected in increased scores for hepatic steatosis, inflammation, fibrosis and NASH. This study suggests the complex interplay of multiple organs in the pathogenesis of obesity-related complications such as NAFLD and provides further evidence supporting an important role for gastric tissue in promoting obesity-related complications.


Subject(s)
Energy Metabolism/genetics , Gastric Mucosa/metabolism , Non-alcoholic Fatty Liver Disease/genetics , Obesity/genetics , RNA, Messenger/genetics , Adult , Carboxypeptidase H/genetics , Cohort Studies , Down-Regulation , Female , Gene Expression Profiling , Humans , Interleukin-1beta/genetics , Leptin/genetics , Male , Middle Aged , Non-alcoholic Fatty Liver Disease/complications , Obesity/complications , Real-Time Polymerase Chain Reaction , Receptor, Cannabinoid, CB1/genetics , Receptors, Adrenergic, alpha-2/genetics , Severity of Illness Index , Up-Regulation
13.
Am J Phys Med Rehabil ; 93(6): 470-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24398583

ABSTRACT

OBJECTIVE: The aim of this study was to assess whether physical performance correlates with metabolic and inflammatory measures in research subjects with chronic liver disease. DESIGN: This is a prospective, descriptive cohort study correlating performance on a 6-min walk test with cardiorespiratory variables, metabolic measures (glucose [GLU], C-peptide insulin, and lipids), liver enzymes (aspartate aminotransferase and alanine aminotransferase), and the proinflammatory cytokine interleukin-8 (IL-8). RESULTS: This study enrolled 51 subjects (18 women) with chronic liver disease: 41% (n = 21) with nonalcoholic fatty liver disease and 59% (n = 30) with hepatitis C virus. Age, resting heart rate, and fasting GLU correlated significantly with distance walked (P's < 0.05). First quartile "poor performers" (n = 14) and fourth quartile "high performers" (n = 14) showed differences in age, sex, fasting GLU, and IL-8 level (P's < 0.05). Combining the number of abnormal serum values (IL-8, C-peptide insulin, GLU, aspartate aminotransferase, alanine aminotransferase, high-density lipoprotein, triglyceride, and total cholesterol) did not correlate with distance walked (P > 0.90). However, in multiple regression analysis, a model that included sex, age, resting heart rate, IL-8 level, and fasting GLU level explained approximately 39% of the variance in the distance walked during the test. CONCLUSIONS: Older age, female sex, abnormal levels of the proinflammatory cytokine IL-8, abnormalities of GLU metabolism, and high resting heart rate are associated with poor physical performance in subjects with chronic liver disease. Poor physical performance is associated with physiologic, metabolic, and inflammatory abnormalities in subjects with nonalcoholic fatty liver disease and hepatitis C virus.


Subject(s)
Exercise Test , Fatty Liver/physiopathology , Hepatitis C, Chronic/physiopathology , Physical Fitness/physiology , Walking/physiology , Age Factors , Blood Glucose/analysis , Female , Heart Rate/physiology , Humans , Interleukin-8/blood , Male , Middle Aged , Prospective Studies , Regression Analysis , Rest/physiology , Sex Factors
14.
Clin Liver Dis ; 18(1): 41-58, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24274864

ABSTRACT

Obesity is one of the most important health challenges faced by developed countries and is increasingly affecting adolescents and children. Obesity is also a considerable risk factor for the development of numerous other chronic diseases, such as insulin resistance, type 2 diabetes, heart disease and nonalcoholic fatty liver disease. The epidemic proportions of obesity and its numerous comorbidities are bringing into focus the highly complex and metabolically active adipose tissue. Adipose tissue is increasingly being considered as a functional endocrine organ. This article discusses the endocrine effects of adipose tissue during obesity and the systemic impact of this signaling.


Subject(s)
Intra-Abdominal Fat/physiopathology , Adipokines/physiology , Chronic Disease , Cytokines/physiology , Endocrine Glands/physiopathology , Female , Humans , Hypoxia/physiopathology , Inflammation/physiopathology , Insulin Resistance , Male , Obesity/complications , Obesity/physiopathology , Signal Transduction
15.
Clin Liver Dis ; 18(1): 249-67, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24274878

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is a complex disease. The considerable variability in the natural history of the disease suggests an important role for genetic variants in the disease development and progression. There is evidence based on genome-wide association studies and/or candidate gene studies that genetic polymorphisms underlying insulin signaling, lipid metabolism, oxidative stress, fibrogenesis, and inflammation can predispose individuals to NAFLD. This review highlights some of the genetic variants in NAFLD.


Subject(s)
Fatty Liver/etiology , Fatty Liver/genetics , Obesity/complications , Obesity/genetics , Adipogenesis/genetics , Apolipoprotein C-III/genetics , Carrier Proteins/genetics , Fatty Liver/metabolism , Genetic Association Studies , Hemochromatosis Protein , Histocompatibility Antigens Class I/genetics , Humans , Lipase/genetics , Lipid Metabolism/genetics , Liver/metabolism , Membrane Proteins/genetics , Non-alcoholic Fatty Liver Disease , Obesity/metabolism , Peroxisome Proliferator-Activated Receptors/genetics , Phosphatidate Phosphatase/genetics , Phosphatidylethanolamine N-Methyltransferase/genetics , Polymorphism, Single Nucleotide , Receptors, Adrenergic, beta/genetics , Triglycerides/metabolism
16.
J Transl Med ; 11: 133, 2013 May 31.
Article in English | MEDLINE | ID: mdl-23721173

ABSTRACT

BACKGROUND: Polycystic ovarian syndrome (PCOS) is one of the most common reproductive disorders with strong association with both insulin resistance and non-alcoholic fatty liver disease (NAFLD). To untangle the complex relationship between PCOS and NAFLD, we analyzed serum biomarkers of apoptosis, some adipokines and mRNA profiles in the visceral adipose tissue of obese patients with NAFLD who were also diagnosed with PCOS and compared to a group with NAFLD only. METHODS: We included patients with biopsy-proven NAFLD and PCOS (N = 12) and BMI-matched biopsy-proven NAFLD patients without PCOS (N = 12). Expression levels of individual mRNAs and soluble serum biomarkers were compared by non-parametric Mann-Whitney test. The analysis also included Spearman rank correlation tests and multiple regression analysis. For co-correlated genes, the factor analysis was performed. RESULTS: The total serum levels of apoptotic biomarker M30 were significantly elevated in PCOS patients with liver steatosis as compared to non-PCOS NAFLD controls (P < 0.02), pointing that androgen-dependent proapoptotic PCOS environment that may directly contribute to NAFLD progression in these patients. Similarly, hyperandrogenism may explain the observed PCOS-specific decrease (P < 0.04) in adipose LDLR mRNA expression that may be connected to the proneness of PCOS patients to NAFLD. The levels of mRNA encoding angiogenesis-associated GSK-3B interacting protein ninein were also significantly increased in the adipose tissue of NAFLD patients with PCOS (P < 0.007). Furthermore, the levels of resistin positively correlated with expression levels of LDLR and prothrombin time (PT). CONCLUSION: An androgen-dependent proapoptotic PCOS environment may directly contribute to NAFLD progression in these patients. Hyperandrogenism may explain an observed decrease in adipose LDLR mRNA expression. An inflammation-associated increase in the release of resistin into circulation might contribute to the prothrombotic state observed under conditions associated with insulin resistance, including PCOS. The studies of larger cohorts of NAFLD with and without PCOS patients are needed to further assess these potential interactions.


Subject(s)
Adipose Tissue/metabolism , Fatty Liver/metabolism , Polycystic Ovary Syndrome/metabolism , Adipokines/metabolism , Adult , Androgens/metabolism , Apoptosis , Biomarkers/metabolism , Body Mass Index , Cytoskeletal Proteins/metabolism , Disease Progression , Female , Humans , Insulin Resistance , Keratin-18/metabolism , Middle Aged , Non-alcoholic Fatty Liver Disease , Nuclear Proteins/metabolism , Peptide Fragments/metabolism , RNA, Messenger/metabolism , Receptors, LDL/metabolism , Regression Analysis , Resistin/metabolism
17.
J Gastroenterol Hepatol ; 28(8): 1410-5, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23663110

ABSTRACT

BACKGROUND AND AIM: Recently, microRNAs (miRNA) have been linked to the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH). First transcribed as pri-miRNA, these molecules are further processed by a complex of endonuclear and cytosolic RNA binding molecules to form mature miRNAs. The aim of this study is to investigate mechanisms of miRNA regulation in the visceral adipose of obese NAFLD patients via measuring expression of miRNA processing enzymes and pri-miRNA. METHODS: Total RNAs were extracted from visceral adipose tissue (VAT) samples collected from patients undergoing bariatric surgery. All patients had biopsy-proven NAFLD (NASH patients [n = 12] and non-NASH NAFLD [n = 12]). For each patient, we profiled mRNA levels for three miRNA processing elements (Drosha, DGCR8, and Dicer1) and seven pri-miRNAs (pri-miR-125b-2, pri-miR-16-2, pri-miR-26a-1, pri-miR-26a-2, pri-miR-7-1, pri-miR-7-2, and pri-miR-7-3). RESULTS: Expression of Dicer1, Drosha and DGCR8 was significantly increased within the NASH cohort along with expression of pri-miR-7-1. The presence of focal necrosis on the liver biopsy correlated significantly with levels of Dicer1 and DGRC8. Both NASH and ballooning degeneration of hepatocytes correlated negatively with the expression levels of hsa-miR-125b. Histologic NASH correlated positively with the expression levels of pri-miR-16-2 and pri-miR-7-1. The presence of the hepatocyte's ballooning degeneration in the liver biopsy correlated positively with pri-miR-26a-1 and pri-miR-7-1. The expression profile of pri-miR-125b-2 also correlated positively with body mass index. CONCLUSIONS: Our findings support the hypothesis that VAT-derived miRNA may contribute to the pathogenesis of NASH in obese patients.


Subject(s)
DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/metabolism , Fatty Liver/enzymology , Fatty Liver/genetics , Gene Expression Regulation, Enzymologic/genetics , MicroRNAs/genetics , MicroRNAs/metabolism , Proteins/genetics , Proteins/metabolism , Ribonuclease III/genetics , Ribonuclease III/metabolism , Adult , Body Mass Index , Cohort Studies , Disease Progression , Fatty Liver/pathology , Female , Humans , Intra-Abdominal Fat/enzymology , Intra-Abdominal Fat/metabolism , Liver/pathology , Male , Middle Aged , Necrosis , Non-alcoholic Fatty Liver Disease , Obesity , RNA-Binding Proteins
18.
Mediators Inflamm ; 2013: 684237, 2013.
Article in English | MEDLINE | ID: mdl-23661906

ABSTRACT

Obesity is associated with chronic low-grade inflammation perpetuated by visceral adipose. Other organs, particularly stomach and intestine, may also overproduce proinflammatory molecules. We examined the gene expression patterns in gastric tissue of morbidly obese patients with nonalcoholic fatty liver disease (NAFLD) and compared the changes in gene expression in different histological forms of NAFLD. Stomach tissue samples from 20 morbidly obese NAFLD patients who were undergoing sleeve gastrectomy were profiled using qPCR for 84 genes encoding inflammatory cytokines, chemokines, their receptors, and other components of inflammatory cascades. Interleukin 8 receptor-beta (IL8RB) gene overexpression in gastric tissue was correlated with the presence of hepatic steatosis, hepatic fibrosis, and histologic diagnosis of nonalcoholic steatohepatitis (NASH). Expression levels of soluble interleukin 1 receptor antagonist (IL1RN) were correlated with the presence of NASH and hepatic fibrosis. mRNA levels of interleukin 8 (IL8), chemokine (C-C motif) ligand 4 (CCL4), and its receptor chemokine (C-C motif) receptor type 5 (CCR5) showed a significant increase in patients with advanced hepatic inflammation and were correlated with the severity of the hepatic inflammation. The results of our study suggest that changes in expression patterns for inflammatory molecule encoding genes within gastric tissue may contribute to the pathogenesis of obesity-related NAFLD.


Subject(s)
Fatty Liver/immunology , Fatty Liver/metabolism , Gastric Mucosa/metabolism , Inflammation/metabolism , Stomach/immunology , Adult , Chemokine CCL4/genetics , Chemokines/metabolism , Cytokines/metabolism , Female , Humans , Interleukin 1 Receptor Antagonist Protein/metabolism , Interleukin-8/genetics , Liver/immunology , Liver/metabolism , Liver/pathology , Liver Cirrhosis/immunology , Liver Cirrhosis/metabolism , Male , Middle Aged , Non-alcoholic Fatty Liver Disease , Receptors, CCR5/genetics , Receptors, Interleukin-8B/metabolism
19.
Bioessays ; 35(7): 586-96, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23592240

ABSTRACT

The KCTD family includes tetramerization (T1) domain containing proteins with diverse biological effects. We identified a novel member of the KCTD family, BTBD10. A comprehensive analysis of protein-protein interactions (PPIs) allowed us to put forth a number of testable hypotheses concerning the biological functions for individual KCTD proteins. In particular, we predict that KCTD20 participates in the AKT-mTOR-p70 S6k signaling cascade, KCTD5 plays a role in cytokinesis in a NEK6 and ch-TOG-dependent manner, KCTD10 regulates the RhoA/RhoB pathway. Developmental regulator KCTD15 represses AP-2α and contributes to energy homeostasis by suppressing early adipogenesis. TNFAIP1-like KCTD proteins may participate in post-replication DNA repair through PCNA ubiquitination. KCTD12 may suppress the proliferation of gastrointestinal cells through interference with GABAb signaling. KCTD9 deserves experimental attention as the only eukaryotic protein with a DNA-like pentapeptide repeat domain. The value of manual curation of PPIs and analysis of existing high-throughput data should not be underestimated.


Subject(s)
Cell Differentiation/genetics , Nuclear Proteins/physiology , Repressor Proteins/physiology , Vertebrates/genetics , Animals , DNA Replication , Gene Expression Regulation, Developmental , Humans , Intracellular Signaling Peptides and Proteins , NIMA-Related Kinases , Nuclear Proteins/genetics , Potassium Channels/genetics , Potassium Channels/physiology , Potassium Channels, Voltage-Gated/genetics , Potassium Channels, Voltage-Gated/physiology , Proliferating Cell Nuclear Antigen/genetics , Proliferating Cell Nuclear Antigen/physiology , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/physiology , Repressor Proteins/genetics , Ribosomal Protein S6 Kinases, 70-kDa/genetics , Ribosomal Protein S6 Kinases, 70-kDa/physiology , Signal Transduction , TOR Serine-Threonine Kinases/genetics , TOR Serine-Threonine Kinases/physiology , Ubiquitination
20.
PLoS One ; 8(2): e56009, 2013.
Article in English | MEDLINE | ID: mdl-23405244

ABSTRACT

The discovery of biomarkers is often performed using high-throughput proteomics-based platforms and is limited to the molecules recognized by a given set of purified and validated antigens or antibodies. Knowledge-based, or systems biology, approaches that involve the analysis of integrated data, predominantly molecular pathways and networks may infer quantitative changes in the levels of biomolecules not included by the given assay from the levels of the analytes profiled. In this study we attempted to use a knowledge-based approach to predict biomarkers reflecting the changes in underlying protein phosphorylation events using Nonalcoholic Fatty Liver Disease (NAFLD) as a model. Two soluble biomarkers, CCL-2 and FasL, were inferred in silico as relevant to NAFLD pathogenesis. Predictive performance of these biomarkers was studied using serum samples collected from patients with histologically proven NAFLD. Serum levels of both molecules, in combination with clinical and demographic data, were predictive of hepatic fibrosis in a cohort of NAFLD patients. Our study suggests that (1) NASH-specific disruption of the kinase-driven signaling cascades in visceral adipose tissue lead to detectable changes in the levels of soluble molecules released into the bloodstream, and (2) biomarkers discovered in silico could contribute to predictive models for non-malignant chronic diseases.


Subject(s)
Biomarkers/blood , Chemokine CCL2/blood , Fas Ligand Protein/blood , Fatty Liver/diagnosis , Knowledge Bases , Liver Cirrhosis/diagnosis , Systems Biology , Cohort Studies , Enzyme-Linked Immunosorbent Assay , Fatty Liver/blood , Female , Humans , Liver Cirrhosis/blood , Male , Middle Aged , Non-alcoholic Fatty Liver Disease , Phosphorylation , Proteomics , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...